TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Octapharma Nordic AB
Closing information (x1000 SEK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 31,741,662 | 25,728,161 | 24,015,060 |
Financial expenses | 37,403 | 217,450 | 10,135 |
Earnings before taxes | 5,693,016 | 4,839,136 | 3,947,744 |
EBITDA | 7,246,421 | 6,497,511 | 5,221,177 |
Total assets | 47,108,542 | 39,708,996 | 34,249,815 |
Current assets | 33,692,804 | 27,827,217 | 24,136,575 |
Current liabilities | 4,440,123 | 4,006,545 | 3,105,044 |
Equity capital | 40,274,418 | 33,739,488 | 29,216,962 |
- share capital | 1,335 | 1,230 | 1,003 |
Employees (average) | 9,734 | 8,336 | 8,141 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 85.5% | 85.0% | 85.3% |
Turnover per employee | 3,261 | 3,086 | 2,950 |
Profit as a percentage of turnover | 17.9% | 18.8% | 16.4% |
Return on assets (ROA) | 12.2% | 12.7% | 11.6% |
Current ratio | 758.8% | 694.5% | 777.3% |
Return on equity (ROE) | 14.1% | 14.3% | 13.5% |
Change turnover | 6,013,501 | 1,713,101 | 884,905 |
Change turnover % | 23% | 7% | 4% |
Chg. No. of employees | 1,398 | 195 | 233 |
Chg. No. of employees % | 17% | 2% | 3% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.